Analysis of IgG reactivity against human papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: Results of a prospective study

International Journal of Cancer

Volumn 68, Issue 6, 1996, Pages 731-738

  De Gruijl, Tanja D ^a   Bontkes, Hetty J ^a   Walboomers, Jan M M ^a   Stukart, Marij J ^a   Robbesom, Antoine A J P ^a   Von Blomberg Van Der Flier, B Mary E ^a   Herbrink, Paul ^b   Remmink, Ans J ^a   Verheijen, René H M ^a   Helmerhorst, Theo J M ^a   Meijer, Chris J L M ^a   Scheper, Rik J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0030483559     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961211)68:6<731::AID-IJC7>3.0.CO;2-4     Document Type: Article

References (21)

1. APPLE, R.J., ERLICH, H.A., KLITZ, W., MANOS, M.M., BECKER, T.M. and WHEELER, C.M., HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature (Genet.), 6, 157-162 (1994).
2. BAAY, M.F.D., DUK, J.M., BURGER, M.P.M., DEBRUIJN, H.W.A., STOLZ, E. and HERBRINK, P., Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma. J. med. Virol., 45, 342-347 (1995).
3. 3. J. exp. Med., 179, 757-762 (1994).
4. DE GRUIJL, T.D., BONTKES, H.J., STUKART, M.J., WALBOOMERS, J.M.M., REMMINK, A.J., VERHEIJEN, R.H.M., HELMERHORST, TH.J.M, MEIJER, C.J.L.M. and SCHEPER, R.J., T-cell proliferative responses against the human papillomavirus type-16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection. J. gen. Virol., 77, 2183-2191 (1996).
5. DILLNER, J., Disappearance of antibodies to HPV-16 E7 after treatment for cervical cancer. Lancet, 341, 1594 (1993).
6. DUGGAN-KEEN, M., KEATING, P.J., CROMME, F.V., WALBOOMERS, J.M.M. and STERN, P.L., Alterations in major histocompatibility complex expression in cervical cancer: possible consequences for immunotherapy. Papillomavirus Rep., 5, 3-9 (1994).
7. GISSMANN, L. and MÜLLER, M., Serological immune responses to HPV. In: P.L. Stern and M.A. Stanley (eds.), Human papillomaviruses and cervical cancer; biology and immunology, pp. 132-145, Oxford Medical Publications, Oxford, New York, Tokyo (1994).
8. HAMSIKOVA, E., NOVAK, J., HOFMANNOVA, V., MUÑOZ, N., BOSCH, F.X., DESANJOSE, S., SHAH, K., ROTH, Z. and VONKA, V., Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls. J. infect. Dis., 170, 1424-1431 (1994).
9. IARC, Monographs on the evaluation of carcinogenic risks to humans. Vol. 64, The Human Papillomavirus, IARC, Lyon (1995).
10. 2 deficiency associated with defects in production of interferon-gamma; comparison with common variable immunodeficiency. Scand. J. Immunol., 41, 130-134 (1995).
11. 2. J. Immunol., 153, 4948-4958 (1995).
12. KRCHNAK, V., VAGNER, J., SUCHANKOVA, A., KRCMAR, M., RITTEROVA, L. and VONKA, V., Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J. gen. Virol., 71, 2719-2724 (1990).
13. MÜLLER, M., VISCIDI, R.P., SUN, Y., GUERRERO, E., HILL, P.M., SHAH, F., BOSCH, F.X., MUÑOZ, N., GISSMANN, L. and SHAH, K., Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. Virology, 187, 508-514 (1992).
14. MÜLLER, M., VISCIDI, R.P., ULKEN, V., BAVINCK, J.N.B., HILL, P.M., FISHER, S.G., REID, R., MUÑOZ, N., SCHNEIDER, A., SHAH, K.V. and GISSMANN, L., Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. J. invest. Dermatol., 104, 138-141 (1995).
15. NINDL, I., BENITEZBRIBIESCA, L., BERUMEN, J., FARMANARA, N., FISHER, S., GROSS, G., LOPEZCARILLO, L., MULLER, M., TOMMASINO, M., VAZQUEZCURIEL, A. and GISSMANN, L., Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients. Arch. Virol., 137, 341-353 (1994).
16. REMMINK, A.J., WALBOOMERS, J.M.M., HELMERHORST, TH.J.M., VOOR-HORST, F.J., ROZENDAAL, L., RISSE, E.K.J., MEIJER, C.J.L.M. and KENEMANS, P., The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer, 61, 306-311 (1995).
17. SCHAFER, A., FRIEMANN, W., MIELKE, M., SCHWATLANDER, B. and KOCH, M.A., The increased frequency of cervical dysplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Amer. J. Obstet. Gynecol., 164, 593-599 (1991).
18. SCHILLER, J.T. and RODEN, R.B.S., Papillomavirus-like particles. Papillomavirus Rep., 6, 121-128 (1995).
19. SPIEGELBERG, H.L., BECK, L., KOCHER, H.P., FANSLOW, W.C. and LUCAS, A.H., Role of Interleukin-4 in human Immunoglobulin E formation in hu-PBL-SCID mice. J. clin. Invest., 93, 711-717 (1994).
20. STANLEY, M.A., Virus-keratinocyte interactions in the infectious cycle. In: P.L. Stern and M.A. Stanley (eds.), Human papillomaviruses and cervical cancer, biology and immunology, pp. 116-128, Oxford Medical Publications, Oxford, New York, Tokyo (1994).
21. VISCIDI, R.P., SUN, Y., TSUZAKI, B., BOSCH, F.X., MUNÑOZ, N. and SHAH, K.V., Serologic response in human papillomavirus-associated invasive cervical cancer. Int. J. Cancer, 55, 780-784 (1993).